Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease
Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease
复制标题
DOI:
10.1016/j.rmed.2009.01.021
复制
发表时间:
2009-08-01
影响因子:
4.3
通讯作者:
Tohda, Yuji
中科院分区:
文献类型:
--
作者:
Higashimoto, Yuji;Iwata, Takuya;Tohda, Yuji
Background: Recent studies show that COPD patients exhibit low-grade systemic inflammation, and that plasma fibrinogen and high neutrophil. counts are related to faster declines in lung function. We examined correlations between serum biomarkers and the decline of lung function in COPD patients.Method: Baseline levels of 9 serum biomarkers (TIMP-1, alpha 1-antitrypsin, MMP-9, TNF-alpha, TGF-beta, IL-6, IL-8, neutrophil. elastase and CRP), fibrinogen and white blood cell. counts (WCC) were measured in 96 COPD patients. Lung function was measured at the time of blood sampling and every 3-6 months during the observation period (median 25.0 months).Results: Twenty patients were rapid decliners of tung function and 53 patients were non-decliners. Neutrophil. counts, serum CRP and MMP-9 were significantly higher in the rapid decliners (p < 0.05). The annual change of % predicted FEV1 was inversely correlated with MMP-9 (r = -0.288; p < 0.01) and CRP (r = -0.354; p < 0.005) (partial correlation coefficients adjusted for age, sex, cardiovascular disease, smoking history, and baseline % predicted FEV1). The remaining biomarkers were not correlated with the annual change of % predicted FEV1.Conclusion: Serum CRP and MMP-9 levels were related to FEV1 decline. These markers are good candidates as predictors for rapid decline of FEV1 in COPD patients. Additional long-term and larger size studies of COPD patients could help determine the exact rotes for these biomarkers. (C) 2009 Elsevier Ltd. All. rights reserved.